Transplantation

Current Opinion in Immunology

Volumn 14, Issue 5, 2002, Pages 559-561

  Brinkmann, Volker ^a   Lynch, Kevin R ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; B LYMPHOCYTE; CELL FUNCTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; TRANSPLANTATION; XENOTRANSPLANTATION;

EID: 0036774835     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00390-4     Document Type: Editorial

References (2)

1. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol Rev. 182:2001;68-79.
2. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:2002;41-49.